Tag Archives: Medicines

Leukeran chlorambucil pricing – Aspen being investigated by EC for alleged overpricing

Cancer Drugs

Aspen Pharma is being formally investigated by the European Commission on charges of excessively pricing its five life-saving cancer medicines including Leukeran chlorambucil. The European Commission’s investigation comes a short time after Italian Competition Authority (ICA), which fined Aspen Pharma over €5 million in September 2016 for charging allegedly excessive ...

Read More »